Skip to main content
. Author manuscript; available in PMC: 2009 Aug 1.
Published in final edited form as: Bioorg Med Chem Lett. 2008 Jul 2;18(15):4294–4297. doi: 10.1016/j.bmcl.2008.06.093

Table 2.

Bacterial inhibition and potentiation results for 2-aryl analogues of INF55 (2) with berberine in S. aureus. NP denotes no antibacterial potentiation. The inhibitor concentrations are the minimum for potentiation of berberine MIC by factors of 3.3 (K1758), 3.3 (8325-4), and 13.3 (K2378).

graphic file with name nihms64957t2.jpg MIC (µM) of inhibitor

Δ norA K1758 plus berberine WT 8325-4 plus berberine NorA++ K2378 plus berberine
Compd R1 R2
32 H 2′-CO2Me NP 20 20
33 H 2′-CH2OH NP 45 45
18 H 3′-CO2Me 40 5 10
19 H 3′-CH2OH NP 45 45
22 H 4′-CO2Me NP 20 40
23 H 4′-CH2OH NP 22 45
225 NO2 H 0.63 1.3 1.3
34 NO2 2′-CO2Me NP 34 NP
3513 NO2 2′-CH2OH 24 47 47
20 NO2 3′-CO2Me 0.51 1.0 1.0
21 NO2 3′-CH2OH 9 5 9
24 NO2 4′-CO2Me NP 17 NP
25 NO2 4′-CH2OH 5 2 2